Insider Transactions in Q1 2022 at West Pharmaceutical Services Inc (WST)
Insider Transaction List (Q1 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 14
2022
|
Quintin J Lai VP Strat & Investor Relations |
SELL
Open market or private sale
|
Direct |
8,016
-10.19%
|
$2,973,936
$371.26 P/Share
|
|
Mar 14
2022
|
Quintin J Lai VP Strat & Investor Relations |
BUY
Exercise of conversion of derivative security
|
Direct |
8,016
+26.6%
|
$705,408
$88.87 P/Share
|
|
Feb 22
2022
|
Eric Mark Green President, CEO and Board Chair |
BUY
Grant, award, or other acquisition
|
Direct |
22,104
+16.87%
|
$8,156,376
$369.13 P/Share
|
|
Feb 22
2022
|
Bernard Birkett Sr VP, Chief Fin & Ops Off |
BUY
Grant, award, or other acquisition
|
Direct |
4,346
+21.45%
|
$1,603,674
$369.13 P/Share
|
|
Feb 22
2022
|
Silji Abraham SVP, Chief Technology Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,498
+22.56%
|
$921,762
$369.13 P/Share
|
|
Feb 22
2022
|
Annette F Favorite Sr. VP & Chief HR Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,490
+15.94%
|
$918,810
$369.13 P/Share
|
|
Feb 22
2022
|
Chad Winters VP, Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
414
+27.86%
|
$152,766
$369.13 P/Share
|
|
Feb 22
2022
|
Kimberly Banks Mac Kay SVP, GC & Corporate Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
310
+50.0%
|
$114,390
$369.13 P/Share
|
|
Feb 22
2022
|
Quintin J Lai VP Strat & Investor Relations |
BUY
Grant, award, or other acquisition
|
Direct |
3,138
+36.88%
|
$1,157,922
$369.13 P/Share
|
|
Feb 22
2022
|
David A Montecalvo SVP, Glob Ops and Supply Chain |
BUY
Grant, award, or other acquisition
|
Direct |
3,597
+20.76%
|
$1,327,293
$369.13 P/Share
|
|
Feb 13
2022
|
Eric Mark Green President, CEO and Board Chair |
SELL
Payment of exercise price or tax liability
|
Direct |
85
-0.1%
|
$33,235
$391.2 P/Share
|
|
Feb 13
2022
|
David A Montecalvo SVP, Glob Ops and Supply Chain |
SELL
Payment of exercise price or tax liability
|
Direct |
27
-0.27%
|
$10,557
$391.2 P/Share
|